nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2B6—Thiotepa—hematologic cancer	0.0437	0.05	CbGbCtD
Brompheniramine—CYP2E1—Thalidomide—hematologic cancer	0.0286	0.0327	CbGbCtD
Brompheniramine—CYP2C9—Bexarotene—hematologic cancer	0.0279	0.0319	CbGbCtD
Brompheniramine—CYP2B6—Ifosfamide—hematologic cancer	0.0248	0.0284	CbGbCtD
Brompheniramine—CYP2E1—Dacarbazine—hematologic cancer	0.0246	0.0281	CbGbCtD
Brompheniramine—CYP2C8—Bortezomib—hematologic cancer	0.0245	0.028	CbGbCtD
Brompheniramine—CYP2D6—Lomustine—hematologic cancer	0.0237	0.0271	CbGbCtD
Brompheniramine—CYP2C9—Idarubicin—hematologic cancer	0.0231	0.0264	CbGbCtD
Brompheniramine—CYP2B6—Nilotinib—hematologic cancer	0.0215	0.0246	CbGbCtD
Brompheniramine—CYP2D6—Idarubicin—hematologic cancer	0.0211	0.0242	CbGbCtD
Brompheniramine—CYP2C19—Bortezomib—hematologic cancer	0.0205	0.0235	CbGbCtD
Brompheniramine—CYP2E1—Mitoxantrone—hematologic cancer	0.0191	0.0218	CbGbCtD
Brompheniramine—CYP2C8—Ifosfamide—hematologic cancer	0.0188	0.0215	CbGbCtD
Brompheniramine—CYP2D6—Hydroxyurea—hematologic cancer	0.018	0.0206	CbGbCtD
Brompheniramine—CYP2C19—Thalidomide—hematologic cancer	0.0179	0.0205	CbGbCtD
Brompheniramine—CYP2C9—Bortezomib—hematologic cancer	0.0171	0.0196	CbGbCtD
Brompheniramine—CYP2C19—Teniposide—hematologic cancer	0.0171	0.0195	CbGbCtD
Brompheniramine—CYP2C8—Nilotinib—hematologic cancer	0.0163	0.0187	CbGbCtD
Brompheniramine—CYP3A4—Bexarotene—hematologic cancer	0.0162	0.0185	CbGbCtD
Brompheniramine—CYP2C19—Ifosfamide—hematologic cancer	0.0158	0.018	CbGbCtD
Brompheniramine—CYP2D6—Bortezomib—hematologic cancer	0.0156	0.0179	CbGbCtD
Brompheniramine—CYP3A4—Busulfan—hematologic cancer	0.0151	0.0172	CbGbCtD
Brompheniramine—CYP3A4—Lomustine—hematologic cancer	0.0151	0.0172	CbGbCtD
Brompheniramine—CYP2C19—Imatinib—hematologic cancer	0.0151	0.0172	CbGbCtD
Brompheniramine—CYP2C9—Thalidomide—hematologic cancer	0.0149	0.017	CbGbCtD
Brompheniramine—CYP2B6—Irinotecan—hematologic cancer	0.0148	0.0169	CbGbCtD
Brompheniramine—CYP2C9—Teniposide—hematologic cancer	0.0142	0.0162	CbGbCtD
Brompheniramine—CYP3A4—Thiotepa—hematologic cancer	0.0134	0.0154	CbGbCtD
Brompheniramine—CYP2C9—Ifosfamide—hematologic cancer	0.0131	0.015	CbGbCtD
Brompheniramine—CYP2C9—Imatinib—hematologic cancer	0.0125	0.0143	CbGbCtD
Brompheniramine—CYP2B6—Cisplatin—hematologic cancer	0.0121	0.0138	CbGbCtD
Brompheniramine—CYP2E1—Etoposide—hematologic cancer	0.012	0.0138	CbGbCtD
Brompheniramine—CYP2D6—Imatinib—hematologic cancer	0.0114	0.0131	CbGbCtD
Brompheniramine—CYP2C9—Nilotinib—hematologic cancer	0.0114	0.013	CbGbCtD
Brompheniramine—CYP3A4—Methoxsalen—hematologic cancer	0.0104	0.012	CbGbCtD
Brompheniramine—CYP2D6—Nilotinib—hematologic cancer	0.0104	0.0119	CbGbCtD
Brompheniramine—CYP2D6—Vinorelbine—hematologic cancer	0.0103	0.0118	CbGbCtD
Brompheniramine—CYP3A4—Bortezomib—hematologic cancer	0.00993	0.0114	CbGbCtD
Brompheniramine—CYP2C19—Prednisone—hematologic cancer	0.00992	0.0114	CbGbCtD
Brompheniramine—CYP2E1—Dexamethasone—hematologic cancer	0.00988	0.0113	CbGbCtD
Brompheniramine—CYP2B6—Dexamethasone—hematologic cancer	0.00975	0.0112	CbGbCtD
Brompheniramine—CYP3A4—Daunorubicin—hematologic cancer	0.0095	0.0109	CbGbCtD
Brompheniramine—CYP2C8—Etoposide—hematologic cancer	0.00898	0.0103	CbGbCtD
Brompheniramine—CYP3A4—Cytarabine—hematologic cancer	0.00838	0.00959	CbGbCtD
Brompheniramine—CYP3A4—Teniposide—hematologic cancer	0.00826	0.00945	CbGbCtD
Brompheniramine—CYP2B6—Doxorubicin—hematologic cancer	0.00808	0.00925	CbGbCtD
Brompheniramine—CYP3A4—Ifosfamide—hematologic cancer	0.00762	0.00872	CbGbCtD
Brompheniramine—CYP2C8—Dexamethasone—hematologic cancer	0.00738	0.00845	CbGbCtD
Brompheniramine—CYP3A4—Imatinib—hematologic cancer	0.00728	0.00833	CbGbCtD
Brompheniramine—CYP3A4—Ruxolitinib—hematologic cancer	0.00685	0.00784	CbGbCtD
Brompheniramine—CYP3A4—Nilotinib—hematologic cancer	0.00661	0.00757	CbGbCtD
Brompheniramine—CYP3A4—Vinorelbine—hematologic cancer	0.00656	0.00751	CbGbCtD
Brompheniramine—CYP2C9—Cisplatin—hematologic cancer	0.00637	0.00729	CbGbCtD
Brompheniramine—CYP2D6—Vinblastine—hematologic cancer	0.00636	0.00727	CbGbCtD
Brompheniramine—CYP2C19—Dexamethasone—hematologic cancer	0.00619	0.00709	CbGbCtD
Brompheniramine—CYP3A4—Triamcinolone—hematologic cancer	0.006	0.00686	CbGbCtD
Brompheniramine—CYP3A4—Dasatinib—hematologic cancer	0.00585	0.00669	CbGbCtD
Brompheniramine—CYP3A4—Mitoxantrone—hematologic cancer	0.00577	0.00661	CbGbCtD
Brompheniramine—CYP2C9—Dexamethasone—hematologic cancer	0.00515	0.00589	CbGbCtD
Brompheniramine—CYP3A4—Betamethasone—hematologic cancer	0.00515	0.00589	CbGbCtD
Brompheniramine—CYP3A4—Prednisolone—hematologic cancer	0.00508	0.00581	CbGbCtD
Brompheniramine—CYP3A4—Prednisone—hematologic cancer	0.0048	0.00549	CbGbCtD
Brompheniramine—CYP2D6—Dexamethasone—hematologic cancer	0.00471	0.00539	CbGbCtD
Brompheniramine—CYP3A4—Irinotecan—hematologic cancer	0.00455	0.0052	CbGbCtD
Brompheniramine—CYP3A4—Vinblastine—hematologic cancer	0.00404	0.00463	CbGbCtD
Brompheniramine—CYP3A4—Vincristine—hematologic cancer	0.00397	0.00455	CbGbCtD
Brompheniramine—CYP2D6—Doxorubicin—hematologic cancer	0.00391	0.00447	CbGbCtD
Brompheniramine—CYP3A4—Etoposide—hematologic cancer	0.00364	0.00417	CbGbCtD
Brompheniramine—CYP3A4—Dexamethasone—hematologic cancer	0.00299	0.00343	CbGbCtD
Brompheniramine—CYP3A4—Doxorubicin—hematologic cancer	0.00248	0.00284	CbGbCtD
Brompheniramine—CHRM4—testis—hematologic cancer	0.0007	0.0686	CbGeAlD
Brompheniramine—CYP2C19—hematopoietic system—hematologic cancer	0.000519	0.0509	CbGeAlD
Brompheniramine—KCNH2—hematopoietic system—hematologic cancer	0.000495	0.0485	CbGeAlD
Brompheniramine—CYP2C8—hematopoietic system—hematologic cancer	0.000453	0.0444	CbGeAlD
Brompheniramine—CYP2B6—hematopoietic system—hematologic cancer	0.000406	0.0398	CbGeAlD
Brompheniramine—CYP2C9—hematopoietic system—hematologic cancer	0.000402	0.0395	CbGeAlD
Brompheniramine—HRH1—hematopoietic system—hematologic cancer	0.000397	0.0389	CbGeAlD
Brompheniramine—CYP2E1—hematopoietic system—hematologic cancer	0.000381	0.0374	CbGeAlD
Brompheniramine—CHRM1—lung—hematologic cancer	0.000362	0.0355	CbGeAlD
Brompheniramine—CYP2C19—blood—hematologic cancer	0.000344	0.0337	CbGeAlD
Brompheniramine—KCNH2—blood—hematologic cancer	0.000328	0.0322	CbGeAlD
Brompheniramine—KCNH2—bone marrow—hematologic cancer	0.000317	0.0311	CbGeAlD
Brompheniramine—CYP2B6—gonad—hematologic cancer	0.000309	0.0303	CbGeAlD
Brompheniramine—CYP3A4—hematopoietic system—hematologic cancer	0.000307	0.0301	CbGeAlD
Brompheniramine—CHRM3—testis—hematologic cancer	0.000306	0.03	CbGeAlD
Brompheniramine—CYP2D6—hematopoietic system—hematologic cancer	0.000302	0.0296	CbGeAlD
Brompheniramine—CYP2C8—blood—hematologic cancer	0.0003	0.0294	CbGeAlD
Brompheniramine—KCNH2—testis—hematologic cancer	0.000271	0.0266	CbGeAlD
Brompheniramine—CYP2B6—blood—hematologic cancer	0.000269	0.0264	CbGeAlD
Brompheniramine—CYP2C9—blood—hematologic cancer	0.000267	0.0261	CbGeAlD
Brompheniramine—CYP2E1—blood—hematologic cancer	0.000253	0.0248	CbGeAlD
Brompheniramine—CYP2C8—testis—hematologic cancer	0.000248	0.0243	CbGeAlD
Brompheniramine—CYP2B6—lung—hematologic cancer	0.000236	0.0231	CbGeAlD
Brompheniramine—HRH1—lung—hematologic cancer	0.00023	0.0226	CbGeAlD
Brompheniramine—CYP2B6—testis—hematologic cancer	0.000223	0.0218	CbGeAlD
Brompheniramine—CYP2E1—lung—hematologic cancer	0.000221	0.0217	CbGeAlD
Brompheniramine—HRH1—testis—hematologic cancer	0.000217	0.0213	CbGeAlD
Brompheniramine—CYP2E1—testis—hematologic cancer	0.000209	0.0205	CbGeAlD
Brompheniramine—CYP3A4—blood—hematologic cancer	0.000203	0.0199	CbGeAlD
Brompheniramine—CYP2D6—blood—hematologic cancer	0.0002	0.0196	CbGeAlD
Brompheniramine—KCNH2—lymph node—hematologic cancer	0.000197	0.0193	CbGeAlD
Brompheniramine—CYP2D6—testis—hematologic cancer	0.000165	0.0162	CbGeAlD
Brompheniramine—HRH1—lymph node—hematologic cancer	0.000158	0.0155	CbGeAlD
Brompheniramine—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	4.53e-06	3.91e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	4.53e-06	3.91e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	4.52e-06	3.89e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—STAT3—hematologic cancer	4.51e-06	3.89e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	4.5e-06	3.88e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NRAS—hematologic cancer	4.5e-06	3.88e-05	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	4.49e-06	3.87e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	4.49e-06	3.87e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SRC—hematologic cancer	4.48e-06	3.86e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ALB—hematologic cancer	4.48e-06	3.86e-05	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	4.48e-06	3.86e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	4.46e-06	3.85e-05	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	4.46e-06	3.85e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	4.46e-06	3.84e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	4.44e-06	3.82e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	4.42e-06	3.81e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	4.42e-06	3.81e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	4.41e-06	3.8e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	4.38e-06	3.77e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	4.37e-06	3.76e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—hematologic cancer	4.37e-06	3.76e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.36e-06	3.76e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FGF2—hematologic cancer	4.34e-06	3.74e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FGF2—hematologic cancer	4.33e-06	3.73e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—hematologic cancer	4.32e-06	3.73e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT3—hematologic cancer	4.32e-06	3.73e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MAPK3—hematologic cancer	4.31e-06	3.72e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FGF2—hematologic cancer	4.31e-06	3.72e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NRAS—hematologic cancer	4.31e-06	3.72e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	4.29e-06	3.69e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	4.28e-06	3.69e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	4.27e-06	3.68e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	4.27e-06	3.68e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	4.25e-06	3.67e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	4.21e-06	3.63e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CD44—hematologic cancer	4.21e-06	3.63e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NQO1—hematologic cancer	4.21e-06	3.63e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—hematologic cancer	4.2e-06	3.62e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—hematologic cancer	4.18e-06	3.61e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.18e-06	3.6e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—JAK2—hematologic cancer	4.16e-06	3.59e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—JAK2—hematologic cancer	4.15e-06	3.57e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CREBBP—hematologic cancer	4.14e-06	3.57e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—JAK2—hematologic cancer	4.13e-06	3.56e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MAPK3—hematologic cancer	4.13e-06	3.56e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	4.09e-06	3.53e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	4.08e-06	3.51e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	4.06e-06	3.5e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MDM2—hematologic cancer	4.06e-06	3.5e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTEN—hematologic cancer	4.06e-06	3.5e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	4.05e-06	3.49e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MDM2—hematologic cancer	4.05e-06	3.49e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	4.04e-06	3.48e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MDM2—hematologic cancer	4.04e-06	3.48e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—hematologic cancer	4.02e-06	3.46e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	4.01e-06	3.46e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—hematologic cancer	4.01e-06	3.45e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	4e-06	3.44e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.98e-06	3.43e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.98e-06	3.43e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.96e-06	3.41e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	3.96e-06	3.41e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	3.95e-06	3.41e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MTOR—hematologic cancer	3.95e-06	3.41e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	3.94e-06	3.39e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MTOR—hematologic cancer	3.94e-06	3.39e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	3.93e-06	3.38e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MTOR—hematologic cancer	3.93e-06	3.38e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	3.92e-06	3.38e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	3.89e-06	3.35e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	3.89e-06	3.35e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—KRAS—hematologic cancer	3.88e-06	3.34e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ALB—hematologic cancer	3.87e-06	3.34e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—EP300—hematologic cancer	3.87e-06	3.33e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.81e-06	3.28e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	3.77e-06	3.25e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	3.76e-06	3.24e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	3.75e-06	3.23e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	3.71e-06	3.2e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KRAS—hematologic cancer	3.71e-06	3.2e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	3.71e-06	3.2e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	3.71e-06	3.19e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	3.7e-06	3.19e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.69e-06	3.18e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	3.68e-06	3.18e-05	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	3.67e-06	3.16e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.66e-06	3.16e-05	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	3.66e-06	3.15e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	3.65e-06	3.14e-05	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	3.65e-06	3.14e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CASP3—hematologic cancer	3.63e-06	3.13e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.63e-06	3.13e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—hematologic cancer	3.63e-06	3.13e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CASP3—hematologic cancer	3.62e-06	3.12e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—hematologic cancer	3.62e-06	3.12e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CASP3—hematologic cancer	3.61e-06	3.11e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—hematologic cancer	3.61e-06	3.11e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	3.61e-06	3.11e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—hematologic cancer	3.61e-06	3.11e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—hematologic cancer	3.6e-06	3.1e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—hematologic cancer	3.59e-06	3.09e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	3.58e-06	3.08e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—hematologic cancer	3.57e-06	3.08e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PIK3CA—hematologic cancer	3.56e-06	3.07e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	3.55e-06	3.06e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCND1—hematologic cancer	3.54e-06	3.05e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—JUN—hematologic cancer	3.53e-06	3.04e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCND1—hematologic cancer	3.53e-06	3.04e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—JUN—hematologic cancer	3.52e-06	3.03e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCND1—hematologic cancer	3.52e-06	3.03e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.51e-06	3.03e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—JUN—hematologic cancer	3.51e-06	3.02e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.5e-06	3.02e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTEN—hematologic cancer	3.49e-06	3.01e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	3.48e-06	3e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—JUN—hematologic cancer	3.47e-06	2.99e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALB—hematologic cancer	3.46e-06	2.98e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—hematologic cancer	3.45e-06	2.97e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	3.42e-06	2.95e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	3.42e-06	2.95e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTEN—hematologic cancer	3.42e-06	2.95e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTEN—hematologic cancer	3.41e-06	2.94e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	3.41e-06	2.94e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PIK3CA—hematologic cancer	3.41e-06	2.94e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTEN—hematologic cancer	3.4e-06	2.93e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	3.4e-06	2.93e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.4e-06	2.93e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTEN—hematologic cancer	3.39e-06	2.92e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.37e-06	2.9e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	3.37e-06	2.9e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	3.36e-06	2.9e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	3.34e-06	2.88e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	3.33e-06	2.87e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	3.33e-06	2.87e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—EP300—hematologic cancer	3.33e-06	2.87e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.32e-06	2.86e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	3.32e-06	2.86e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	3.32e-06	2.86e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	3.31e-06	2.85e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.31e-06	2.85e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—hematologic cancer	3.3e-06	2.84e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HRAS—hematologic cancer	3.29e-06	2.84e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	3.29e-06	2.83e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	3.28e-06	2.82e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—EP300—hematologic cancer	3.26e-06	2.81e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EP300—hematologic cancer	3.26e-06	2.81e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EP300—hematologic cancer	3.25e-06	2.8e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EP300—hematologic cancer	3.24e-06	2.79e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.23e-06	2.78e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.23e-06	2.78e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.22e-06	2.78e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EP300—hematologic cancer	3.2e-06	2.76e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.19e-06	2.75e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALB—hematologic cancer	3.18e-06	2.74e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SRC—hematologic cancer	3.17e-06	2.73e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SRC—hematologic cancer	3.16e-06	2.72e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HRAS—hematologic cancer	3.16e-06	2.72e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—hematologic cancer	3.15e-06	2.72e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALB—hematologic cancer	3.15e-06	2.72e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SRC—hematologic cancer	3.15e-06	2.71e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SRC—hematologic cancer	3.12e-06	2.69e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	3.08e-06	2.66e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	3.07e-06	2.65e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	3.06e-06	2.64e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT3—hematologic cancer	3.05e-06	2.63e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	3.05e-06	2.63e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NRAS—hematologic cancer	3.05e-06	2.63e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	3.04e-06	2.62e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	3.04e-06	2.62e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	3.04e-06	2.62e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	3.03e-06	2.62e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	3.03e-06	2.61e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	3.03e-06	2.61e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—hematologic cancer	3.02e-06	2.6e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.02e-06	2.6e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	3e-06	2.59e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	3e-06	2.58e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTEN—hematologic cancer	2.96e-06	2.55e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	2.92e-06	2.51e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AKT1—hematologic cancer	2.91e-06	2.51e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	2.91e-06	2.51e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	2.9e-06	2.5e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	2.87e-06	2.47e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CA—hematologic cancer	2.86e-06	2.47e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.85e-06	2.46e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—hematologic cancer	2.84e-06	2.45e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	2.83e-06	2.44e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—hematologic cancer	2.83e-06	2.44e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	2.82e-06	2.43e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—hematologic cancer	2.82e-06	2.43e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—EP300—hematologic cancer	2.82e-06	2.43e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	2.81e-06	2.42e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.81e-06	2.42e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—hematologic cancer	2.79e-06	2.41e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AKT1—hematologic cancer	2.79e-06	2.4e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	2.79e-06	2.4e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.78e-06	2.4e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTEN—hematologic cancer	2.64e-06	2.27e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KRAS—hematologic cancer	2.62e-06	2.26e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	2.61e-06	2.25e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	2.61e-06	2.25e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	2.58e-06	2.22e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—EP300—hematologic cancer	2.52e-06	2.17e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	2.46e-06	2.12e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.43e-06	2.09e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	2.41e-06	2.08e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	2.41e-06	2.08e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTEN—hematologic cancer	2.41e-06	2.07e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	2.4e-06	2.07e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.4e-06	2.06e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	2.39e-06	2.06e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	2.37e-06	2.04e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AKT1—hematologic cancer	2.34e-06	2.02e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—hematologic cancer	2.33e-06	2.01e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—hematologic cancer	2.32e-06	2e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—hematologic cancer	2.32e-06	2e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—EP300—hematologic cancer	2.31e-06	1.99e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—EP300—hematologic cancer	2.29e-06	1.98e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—hematologic cancer	2.29e-06	1.98e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HRAS—hematologic cancer	2.23e-06	1.92e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	2.22e-06	1.91e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.22e-06	1.91e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	2.21e-06	1.91e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	2.19e-06	1.89e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—hematologic cancer	2.13e-06	1.84e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—hematologic cancer	2.13e-06	1.83e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—hematologic cancer	2.12e-06	1.83e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.11e-06	1.81e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—hematologic cancer	2.1e-06	1.81e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	2.08e-06	1.8e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALB—hematologic cancer	2.08e-06	1.79e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AKT1—hematologic cancer	2.01e-06	1.73e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.99e-06	1.71e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AKT1—hematologic cancer	1.97e-06	1.7e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.97e-06	1.7e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	1.96e-06	1.69e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	1.96e-06	1.69e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	1.94e-06	1.67e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.86e-06	1.6e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.84e-06	1.58e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.71e-06	1.47e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AKT1—hematologic cancer	1.7e-06	1.47e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.7e-06	1.46e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.59e-06	1.37e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.52e-06	1.31e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—EP300—hematologic cancer	1.51e-06	1.3e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.4e-06	1.2e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AKT1—hematologic cancer	1.39e-06	1.19e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.12e-06	9.64e-06	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKT1—hematologic cancer	9.14e-07	7.88e-06	CbGpPWpGaD
